Dexmedetomidine and its increasing application in nonopioid detoxification

Shailendra Kapoor, MD

doi:10.5055/jom.2012.0109

Authors

Shailendra Kapoor, MD

DOI:

https://doi.org/10.5055/jom.2012.0109

Abstract

no abstract

Author Biography

Shailendra Kapoor, MD

Private practice, Mechanicsville, Virginia

References

Nasr DA, Omran HA, Hakim SM, et al.: Ultra-rapid opiate detoxification using dexmedetomidine under general anesthesia. J Opioid Manag. 2011; 7: 337-344.

Kersten JR, Pagel PS, Hettrick DA, et al.: Dexmedetomidine partially attenuates the sympathetically mediated systemic and coronary hemodynamic effects of cocaine. Anesth Analg. 1995; 80: 114-121.

Menon DV, Wang Z, Fadel PJ, et al.: Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans. J Am Coll Cardiol. 2007; 50: 626- 633.

Whittington RA, Virag L, Vulliemoz Y, et al.: Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology. 2002; 97: 693-700.

Farag E, Chahlavi A, Argalious M, et al.: Using dexmedetomidine to manage patients with cocaine and opioid withdrawal, who are undergoing cerebral angioplasty for cerebral vasospasm. Anesth Analg. 2006; 103: 1618-1620.

Javed F, Benjo AM, Reddy K, et al.: Dexmedetomidine use in the setting of cocaine-induced hypertensive emergency and aortic dissection: A novel indication. Case Report Med. 2011; 2011: 174132.

Bagdure DN, Bhoite GR, Reiter PD, et al.: Dexmedetomidine in a child with methylphenidate intoxication. Indian J Pediatr. 2012 (in press).

Finkel JC, Elrefai A: The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant. Anesth Analg. 2004; 98: 1658-1659; Table of contents.

Oschman A, McCabe T, Kuhn RJ: Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients. Am J Health Syst Pharm. 2011; 68: 1233-1238.